VNDA - Vanda updates on FDA review for Hetlioz label expansion
2024-02-05 08:34:42 ET
More on Vanda Pharmaceuticals
- Vanda Pharmaceuticals: FDA Approvals On Deck In 2024 Makes This A Must Watch
- Vanda Pharmaceuticals Inc. (VNDA) Q3 2023 Earnings Call Transcript
- Fed court allows Vanda lawsuit against FDA to move forward
- Biggest stock movers today: Google, AMD, GameStop, C3.AI, Chewy and more
- Seeking Alpha’s Quant Rating on Vanda Pharmaceuticals